Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,958 | -8,395 | -4,378 | -4,054 | 1,453 |
| Depreciation Amortization | 1,236 | 630 | 176 | 42 | 58 |
| Accounts payable and accrued liabilities | 366 | -152 | -32 | -1,930 | -2,337 |
| Other Working Capital | -2,313 | -4,232 | -1,756 | 5,814 | -4,200 |
| Other Operating Activity | 1,339 | 1,261 | 520 | 5,522 | 5,194 |
| Operating Cash Flow | $-11,330 | $-10,888 | $-5,471 | $5,394 | $168 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -179 | -4 | -157 | -573 | -10 |
| Investing Cash Flow | $-179 | $-4 | $-157 | $-573 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 487 | N/A | N/A | 562 | 562 |
| Debt Repayment | -1,289 | -709 | -187 | -581 | -394 |
| Common Stock Issued | 19,655 | 911 | 434 | 454 | 398 |
| Financing Cash Flow | $18,853 | $203 | $247 | $434 | $566 |
| Exchange Rate Effect | 33 | 26 | 13 | -68 | -2 |
| Beginning Cash Position | 15,998 | 15,998 | 15,998 | 10,811 | 10,811 |
| End Cash Position | 23,375 | 5,335 | 10,630 | 15,998 | 11,533 |
| Net Cash Flow | $7,377 | $-10,663 | $-5,368 | $5,187 | $722 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,330 | -10,888 | -5,471 | 5,394 | 168 |
| Capital Expenditure | -179 | -4 | -157 | -573 | -10 |
| Free Cash Flow | -11,509 | -10,892 | -5,628 | 4,821 | 157 |